Elizabeth K. Schorry

6.8k total citations
67 papers, 2.3k citations indexed

About

Elizabeth K. Schorry is a scholar working on Neurology, Epidemiology and Rheumatology. According to data from OpenAlex, Elizabeth K. Schorry has authored 67 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Neurology, 17 papers in Epidemiology and 14 papers in Rheumatology. Recurrent topics in Elizabeth K. Schorry's work include Neurofibromatosis and Schwannoma Cases (46 papers), Meningioma and schwannoma management (14 papers) and Neuroblastoma Research and Treatments (10 papers). Elizabeth K. Schorry is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (46 papers), Meningioma and schwannoma management (14 papers) and Neuroblastoma Research and Treatments (10 papers). Elizabeth K. Schorry collaborates with scholars based in United States, Canada and Australia. Elizabeth K. Schorry's co-authors include Alvin H. Crawford, Howard M. Saal, Anne M. Lovell, Robert J. Hopkin, David Viskochil, Carlos E. Prada, Lisa J. Martin, Bruce R. Korf, Nancy Johnson and Robert B. Noll and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and PEDIATRICS.

In The Last Decade

Elizabeth K. Schorry

64 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth K. Schorry United States 27 1.3k 597 516 471 379 67 2.3k
J.-P. Lejeune France 25 1.3k 1.0× 434 0.7× 223 0.4× 257 0.5× 288 0.8× 118 2.2k
Victor‐Felix Mautner Germany 29 2.1k 1.7× 925 1.5× 567 1.1× 266 0.6× 723 1.9× 116 2.8k
Marie‐Claude Babron France 28 336 0.3× 377 0.6× 428 0.8× 877 1.9× 222 0.6× 94 2.2k
Kerry R. Crone United States 27 884 0.7× 245 0.4× 223 0.4× 235 0.5× 81 0.2× 61 2.3k
Tena Rosser United States 19 597 0.5× 266 0.4× 233 0.5× 185 0.4× 163 0.4× 43 1.1k
I Pascual-Castroviejo Spain 25 579 0.4× 129 0.2× 448 0.9× 495 1.1× 175 0.5× 170 2.1k
Armando Cama Italy 31 438 0.3× 175 0.3× 649 1.3× 400 0.8× 518 1.4× 126 2.8k
Agata Polizzi Italy 22 504 0.4× 152 0.3× 353 0.7× 419 0.9× 208 0.5× 107 1.5k
Thomas Roujeau France 25 781 0.6× 373 0.6× 515 1.0× 264 0.6× 42 0.1× 70 2.1k
Seiji Hama Japan 25 395 0.3× 643 1.1× 555 1.1× 136 0.3× 68 0.2× 71 2.3k

Countries citing papers authored by Elizabeth K. Schorry

Since Specialization
Citations

This map shows the geographic impact of Elizabeth K. Schorry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth K. Schorry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth K. Schorry more than expected).

Fields of papers citing papers by Elizabeth K. Schorry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth K. Schorry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth K. Schorry. The network helps show where Elizabeth K. Schorry may publish in the future.

Co-authorship network of co-authors of Elizabeth K. Schorry

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth K. Schorry. A scholar is included among the top collaborators of Elizabeth K. Schorry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth K. Schorry. Elizabeth K. Schorry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fuller, Christine, et al.. (2024). Compound Heterozygous Variants of GOSR2 Associated With Congenital Muscular Dystrophy and Progressive Myoclonus Epilepsy. Neurology Genetics. 10(4). e200177–e200177.
3.
Aschbacher‐Smith, Lindsey, Allison L. Goetsch, Katherine Kim, et al.. (2024). Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 196(4). e32095–e32095.
4.
Lavery, William J., Artem Barski, Susan Wiley, Elizabeth K. Schorry, & Andrew Lindsley. (2020). KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies. Clinical Epigenetics. 12(1). 10–10. 51 indexed citations
5.
Klesse, Laura J., Justin T. Jordan, Heather B. Radtke, et al.. (2020). The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities. The Oncologist. 25(7). e1109–e1116. 65 indexed citations
6.
Rietman, André B., Sabine E. Mous, Ellen Plasschaert, et al.. (2020). Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1. Genetics in Medicine. 22(5). 889–897. 23 indexed citations
7.
Miller, David T., Debra Freedenberg, Elizabeth K. Schorry, et al.. (2019). Health Supervision for Children With Neurofibromatosis Type 1. PEDIATRICS. 143(5). 117 indexed citations
8.
Weiss, Brian, Scott R. Plotkin, Brigitte C. Widemann, et al.. (2018). NFM-06. NF106: PHASE 2 TRIAL OF THE MEK INHIBITOR PD-0325901 IN ADOLESCENTS AND ADULTS WITH NF1-RELATED PLEXIFORM NEUROFIBROMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY. Neuro-Oncology. 20(suppl_2). i143–i143. 12 indexed citations
9.
Stevenson, David A., David G. Little, Linlea Armstrong, et al.. (2013). Approaches to Treating NF1 Tibial Pseudarthrosis. Journal of Pediatric Orthopaedics. 33(3). 269–275. 44 indexed citations
10.
11.
Johnson, Kimberly, Michael J. Fisher, Robert Listernick, et al.. (2012). Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomas. Familial Cancer. 11(4). 653–656. 5 indexed citations
12.
Prada, Carlos E., et al.. (2011). Lethal presentation of neurofibromatosis and Noonan syndrome. American Journal of Medical Genetics Part A. 155(6). 1360–1366. 16 indexed citations
13.
Hummel, Trent R., Walter J. Jessen, Shyra J. Miller, et al.. (2010). Gene Expression Analysis Identifies Potential Biomarkers of Neurofibromatosis Type 1 Including Adrenomedullin. Clinical Cancer Research. 16(20). 5048–5057. 37 indexed citations
14.
Schorry, Elizabeth K., Sonya Oppenheimer, & Howard M. Saal. (2005). Valproate embryopathy: Clinical and cognitive profile in 5 siblings. American Journal of Medical Genetics Part A. 133A(2). 202–206. 14 indexed citations
15.
Tinkle, Brad T., Elizabeth K. Schorry, David Neal Franz, Kerry R. Crone, & Howard M. Saal. (2005). Epidemiology of hemimegalencephaly: A case series and review. American Journal of Medical Genetics Part A. 139A(3). 204–211. 41 indexed citations
16.
Tang, Yang, Aigang Lu, Ruiqiong Ran, et al.. (2004). Human blood genomics: distinct profiles for gender, age and neurofibromatosis type 1. Molecular Brain Research. 132(2). 155–167. 39 indexed citations
17.
Tinkle, Brad T., et al.. (2003). Long‐term survival in a patient with del(18)(q12.2q21.1). American Journal of Medical Genetics Part A. 119A(1). 66–70. 20 indexed citations
18.
Stevenson, David A., Patricia Birch, Jan M. Friedman, et al.. (1999). Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. American Journal of Medical Genetics. 84(5). 413–419. 96 indexed citations
19.
Crawford, Alvin H. & Elizabeth K. Schorry. (1999). Neurofibromatosis in Children: The Role of the Orthopaedist. Journal of the American Academy of Orthopaedic Surgeons. 7(4). 217–230. 110 indexed citations
20.
Schorry, Elizabeth K., A H Crawford, John C. Egelhoff, Anne M. Lovell, & Howard M. Saal. (1997). Thoracic tumors in children with neurofibromatosis-1. American Journal of Medical Genetics. 74(5). 533–537. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.-P. Lejeune Breakdown of academic impact, for papers by Victor‐Felix Mautner Breakdown of academic impact, for papers by Marie‐Claude Babron Breakdown of academic impact, for papers by Kerry R. Crone Breakdown of academic impact, for papers by Tena Rosser Breakdown of academic impact, for papers by I Pascual-Castroviejo Breakdown of academic impact, for papers by Armando Cama Breakdown of academic impact, for papers by Agata Polizzi Breakdown of academic impact, for papers by Thomas Roujeau Breakdown of academic impact, for papers by Seiji Hama
Rankless by CCL
2026